LIGAND PHARMACEUTICALS INC (LGND) — Congressional trading
Health Care · NASDAQ
LIGAND PHARMACEUTICALS INC (LGND) has 4 reported Congressional stock trading disclosures in our data, including 4 purchases among the most recent 4 (latest 2026-05-29).
Reported STOCK-Act stock transactions
| Trade date | Member | Type | Amount range | Filed | Source |
|---|---|---|---|---|---|
| 2026-05-29 | Hon. Gilbert Cisneros | Purchase | $1,001 – $15,000 | 2026-06-08 | PTR |
| 2026-03-03 | Hon. Gilbert Cisneros | Purchase | $1,001 – $15,000 | 2026-04-07 | PTR |
| 2026-01-15 | Hon. Gilbert Cisneros | Purchase | $1,001 – $15,000 | 2026-02-13 | PTR |
| 2026-01-05 | Hon. Gilbert Cisneros | Purchase | $1,001 – $15,000 | 2026-02-13 | PTR |
Ask the chat about Congressional trading in LGND →
Source: U.S. House Clerk Periodic Transaction Reports (PTRs) filed under the STOCK Act. Disclosure can lag the actual trade by up to 45 days, so these are not real-time. Amounts are broad ranges as legally required — not exact figures. A transaction may belong to the member, their spouse, or a dependent child (see the owner column); a spouse or dependent trade is not the member's personal trade. This information is reused from the official public disclosure record for informational and public-interest (news) purposes only. Informational only — NOT financial advice, and NOT a signal to buy or sell.
See the full company profile: LIGAND PHARMACEUTICALS INC (LGND).
Last updated 2026-05-29 (most recent disclosed transaction date).
Informational only — NOT financial advice. Congressional disclosures are sourced from the U.S. House Clerk public financial-disclosure archive and shown with their reported dates.